These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4338183)

  • 1. Inhibition of pressor effects of angiotensin I and augmentation of depressor effects of bradykinin by synthetic peptides.
    Engel SL; Schaeffer TR; Gold BI; Rubin B
    Proc Soc Exp Biol Med; 1972 May; 140(1):240-4. PubMed ID: 4338183
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition by SQ 20881 of vasopressor response to angiotensin I in conscious animals.
    Bianchi A; Evans DB; Cobb M; Peschka MT; Schaeffer TR; Laffan RJ
    Eur J Pharmacol; 1973 Jul; 23(1):90-6. PubMed ID: 4354808
    [No Abstract]   [Full Text] [Related]  

  • 3. Reduction of pressor effects of angiotensin I in man by synthetic nonapeptide (B.P.P. 9a or SQ 20,881) which inhibits converting enzyme.
    Collier JG; Robinson BF; Vane JR
    Lancet; 1973 Jan; 1(7794):72-4. PubMed ID: 4118651
    [No Abstract]   [Full Text] [Related]  

  • 4. Potentiation of depressor responses to arachidonic acid by angiotensin converting enzyme inhibitors in the rat.
    Hui SC; Dai S; Ogle CW
    Clin Exp Pharmacol Physiol; 1984; 11(6):621-5. PubMed ID: 6100239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for angiotensin-induced hypertension.
    Lancet; 1971 Feb; 1(7693):277-8. PubMed ID: 4100023
    [No Abstract]   [Full Text] [Related]  

  • 6. Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats.
    Paula RD; Lima CV; Khosla MC; Santos RA
    Hypertension; 1995 Dec; 26(6 Pt 2):1154-9. PubMed ID: 7498987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes of plasma renin activity by intracerebroventricular administration of biological active peptides in conscious rats.
    Iwata T; Hashimoto H; Hiwada K; Kokubu T
    Clin Exp Hypertens A; 1984; 6(5):1055-66. PubMed ID: 6375907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bradykinin potentiating factor.
    Greene LJ; Ferreira SH; Stewart JM
    Chest; 1971 May; 59():Suppl:9S-10S. PubMed ID: 4325034
    [No Abstract]   [Full Text] [Related]  

  • 9. Bradykinin potentiating peptide PCA-Lys-Trp-Ala-Pro. An inhibitor of the pulmonary inactivation of bradykinin and conversion of angiotensin I to II.
    Stewart JM; Ferreira SH; Greene LJ
    Biochem Pharmacol; 1971 Jul; 20(7):1557-67. PubMed ID: 4355304
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiotensin-(1-7) potentiates responses to bradykinin but does not change responses to angiotensin I.
    Greco AJ; Master RG; Fokin A; Baber SR; Kadowitz PJ
    Can J Physiol Pharmacol; 2006 Nov; 84(11):1163-75. PubMed ID: 17218981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-(1-7) induces bradykinin-mediated hypotensive responses in anesthetized rats.
    Abbas A; Gorelik G; Carbini LA; Scicli AG
    Hypertension; 1997 Aug; 30(2 Pt 1):217-21. PubMed ID: 9260983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of the central pressor action of bradykinin to the cerebral third ventricle.
    Lewis RE; Phillips MI
    Am J Physiol; 1984 Jul; 247(1 Pt 2):R63-8. PubMed ID: 6742236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of angiotensin I converting enzyme and kininase in rabbit plasma by bradykinin potentiating peptide B (Pyr-Gly-Leu-Pro-Arg-Pro-Lys-Ile-Pro-Pro).
    Ueda E; Kokubu T; Akutsu H; Yamamura Y
    Experientia; 1971 Sep; 27(9):1020-1. PubMed ID: 4329994
    [No Abstract]   [Full Text] [Related]  

  • 14. Alkylating analogs of peptide hormones. 1. Synthesis and properties of p-(N,N-)-bis(2-chloroethyl)amino)phenylbutyryl derivatives of bradykinin and bradykinin potentiating factor.
    Freer RJ; Stewart JM
    J Med Chem; 1972 Jan; 15(1):1-5. PubMed ID: 4331917
    [No Abstract]   [Full Text] [Related]  

  • 15. Potentiation of bradykinin by inhibitors of angiotensin converting enzyme.
    Ryan JW; Carlin G; Berryer P; Chung A
    Adv Exp Med Biol; 1983; 156():613-20. PubMed ID: 6190380
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of the conversion of angiotensin I to II and potentiation of bradykinin by small peptides present in Bothrops jararaca venom.
    Greene LJ; Camargo AC; Krieger EM; Stewart JM; Ferreira SH
    Circ Res; 1972 Sep; 31(9):Suppl 2:62-71. PubMed ID: 4341481
    [No Abstract]   [Full Text] [Related]  

  • 17. Angiotensin II and bradykinin: interactions between two centrally active peptides.
    Lewis RE; Hoffman WE; Phillips MI
    Am J Physiol; 1983 Feb; 244(2):R285-91. PubMed ID: 6337513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of bradykinin and angiotensin-(1-7) in the central modulation of the baroreflex control of the heart rate.
    Bomtempo CA; Santos GF; Santos RA; Campagnole-Santos MJ
    J Hypertens; 1998 Dec; 16(12 Pt 1):1797-804. PubMed ID: 9869014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of blood pressure responses to intra-arterial and intra-venous injections of angiotensin I, angiotensin II and bradykinin.
    Heller LJ; Mohrman DE
    Life Sci; 1998; 62(9):PL121-5. PubMed ID: 9496705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinin receptors of the central nervous system of spontaneously hypertensive rats related to the pressor response to bradykinin.
    Martins DT; Fior DR; Nakaie CR; Lindsey CJ
    Br J Pharmacol; 1991 Aug; 103(4):1851-6. PubMed ID: 1655143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.